A 21-year-old incarcerated man developed pneumothorax, pneumomediastinum, and pneumoperitoneum after synthetic cannabinoid use, highlighting the severe toxicity risks of these substances in prison settings.
Read this if you work in emergency medicine, correctional healthcare, or toxicology.
Multi-cavity air leakPneumothorax, pneumomediastinum, and pneumoperitoneum from synthetic cannabinoid toxicity
What the researchers found
This case report describes a 21-year-old incarcerated male who presented with delayed-onset subcutaneous emphysema, pneumothorax, pneumomediastinum, and pneumoperitoneum following synthetic cannabinoid use with altered mental status. The case highlights both the severe toxicity potential of synthetic cannabinoids and the vulnerability of incarcerated individuals who face delayed medical care and poor follow-up.
Why it matters
Synthetic cannabinoid use is particularly prevalent in prison settings where they are harder to detect on drug tests. This case demonstrates a life-threatening complication that clinicians evaluating synthetic cannabinoid toxicity should consider.
The numbers in context
- 21-year-old male
- Incarcerated at time of presentation
- Complications: subcutaneous emphysema, pneumothorax, pneumomediastinum, pneumoperitoneum
- Delayed presentation
How the study worked
Single case report with clinical description.
Who was studied
Single incarcerated 21-year-old male patient
What this study cannot tell us
Single case report cannot establish prevalence or causation. The mechanism by which synthetic cannabinoids caused air leakage is not established. Other contributing factors (trauma, forceful vomiting) cannot be excluded.
How to read the evidence
Single case report. Documents a rare complication but cannot establish frequency or causation.
When this study was published
Published in 2023. Adds to growing case literature on synthetic cannabinoid complications.
The bigger picture
Synthetic cannabinoid toxicity in prisons represents a convergence of drug policy, healthcare access, and social justice issues. Incarcerated individuals face both higher exposure to these substances and worse access to timely medical care.
Questions still open
- How common are pneumatic complications from synthetic cannabinoid use?
- Should prison healthcare protocols include chest imaging for synthetic cannabinoid toxicity?
- Does the delayed presentation reflect inadequate prison healthcare access?
Read the original research
Subcutaneous Emphysema, Pneumothorax, Pneumomediastinum, and Pneumoperitoneum Following Synthetic Cannabinoid Toxicity in an Incarcerated Man.
The American surgeon, 89(11), 4967-4969
Citation
Gala, Zachary; Kravchenko, Timothy; Volk, Lindsey; Chatani, Praveen; Kar, Reema; Choron, Rachel L. (2023). Subcutaneous Emphysema, Pneumothorax, Pneumomediastinum, and Pneumoperitoneum Following Synthetic Cannabinoid Toxicity in an Incarcerated Man.. The American surgeon, 89(11), 4967-4969. https://doi.org/10.1177/00031348221142589